Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CTSK | P43235 | 2/20 | 0.38 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.35 |
| ▸ | PPARG | P37231 | 2/20 | 0.34 |
| ▸ | PPARA | Q07869 | 2/20 | 0.34 |
| ▸ | CNR1 | P21554 | 2/20 | 0.34 |
| ▸ | CNR2 | P34972 | 2/20 | 0.34 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.34 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.34 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.34 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.34 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.34 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 3/20 | 0.32 |
| ▸ | CES1 | P23141 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4582620 | 1.00 | MAPT (0.43) | MAPTALDH1A1CTSKHDAC6PPARG | |
| SCHEMBL4939392 | 0.96 | MAPT (0.40) | MAPTALDH1A1CTSKPPARGPPARA | |
| SCHEMBL4584290 | 0.96 | MAPT (0.40) | MAPTALDH1A1CTSKPPARGPPARA | |
| SCHEMBL4939380 | 0.95 | PPARG (0.40) | MAPTPPARGPPARASOAT1FAAH | |
| SCHEMBL4582232 | 0.95 | PPARG (0.40) | MAPTPPARGPPARASOAT1FAAH | |
| SCHEMBL5983587 | 0.92 | CTSK (0.40) | MAPTALDH1A1CTSKHDAC6PPARG | |
| SCHEMBL5983589 | 0.92 | CTSK (0.40) | MAPTALDH1A1CTSKHDAC6PPARG | |
| SCHEMBL13969979 | 0.88 | MAPT (0.44) | MAPTALDH1A1PPARGPPARACNR1 | |
| SCHEMBL4582766 | 0.84 | MAPT (0.46) | MAPTALDH1A1PPARGPPARACNR1 | |
| SCHEMBL4938624 | 0.84 | MAPT (0.46) | MAPTALDH1A1PPARGPPARASOAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080076699-A1 | Deconjugated alkadienoic acid esters as fragrances and or aroma substances | SYMRISE GMBH & CO. KG (DE) | 2008-03-27 | — | — | US | claimed |
| US-20080076699-A1 | Deconjugated alkadienoic acid esters as fragrances and or aroma substances | SYMRISE GMBH & CO. KG (DE) | 2008-03-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080076699-A1 | Deconjugated alkadienoic acid esters as fragrances and or aroma substances | DECR1, ALOX12, ALOX15 | MAPT 4488/4885ALDH1A1 21/4885CTSK 3430/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.